Paradoxical effect of aspirin.

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Hemorrhagic Stroke Research

Background:

• Low-dose aspirin is a cost-effective option for secondary prevention of myocardial infarction (MI) and ischemic stroke.
• Aspirin is also used in primary MI prevention, but its risks, particularly hemorrhagic stroke, require careful consideration.
• Balancing aspirin's cardiovascular benefits against hemorrhage risks is crucial for clinical decision-making.

Purpose of the Study:

• To clarify the risks of aspirin use concerning hemorrhagic stroke.
• To investigate the dose-dependent effects of aspirin on hemorrhage.
• To explore the role of cyclooxygenase (COX) enzymes in aspirin-induced bleeding.

Main Methods:

• Normal, COX-1 knockout, and COX-2 knockout mice were used.
• Mice were treated with a wide range of aspirin doses.
• Induced hemorrhagic time was measured to assess bleeding risk.

Main Results:

• High doses of aspirin were found to induce hemorrhage.
• Low doses of aspirin did not significantly increase hemorrhage risk.
• In COX-1 knockout mice, ultra-low aspirin doses showed an anti-hemorrhagic effect, unlike intermediate doses.
• COX-2 deficiency led to a hemorrhagic effect requiring further investigation.

Conclusions:

• Aspirin's effect on hemorrhage is dose-dependent; low doses are generally safe.
• Cyclooxygenase pathways play a critical role in aspirin's impact on bleeding.
• Further research is needed to understand the hemorrhagic effects observed in COX-2 deficient mice.